Comparative pharmacology of the novel cyclopropylpyrroloindole-prodrug carzelesin in mice, rats, and humans.
Olaf van Tellingen(Dutch Cancer Society), J. H. Beijnen, Larry J. Schaaf(Georgetown University), Marc van der Valk(Academic Medical Center), W J Nooijen, Judith van Asperen(University of Groningen), R E Henrar
PubMed
June 1, 1998
Cited by 13
Related Papers
Overcoming the blood–brain tumor barrier for effective glioblastoma treatment
|Drug Resistance Updates|2015|1k
Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins
|Proceedings of the National Academy of Sciences|1997|941
Limited oral bioavailability and active epithelial excretion of paclitaxel (Taxol) caused by P-glycoprotein in the intestine
|Proceedings of the National Academy of Sciences|1997|884